ACA MembersThursday, March 25, 2021 By: Sarah Dickey, ACA Membership Director The programming team for ACA 2021 - The Summit of Angel Investing is full of experienced, respected angel investors and ecosystem providers, and they are hard at work creating a virtual experience that will change the way you think about angel investing. Thursday, March 11, 2021 By: Bridget Weston, CEO of SCORE If you are an entrepreneur building a small business, you know that it takes more than spreadsheets, financial projections, and a big marketing push to reach business success; it also takes passion, dedication, and attention to detail. Friday, February 19, 2021 By: Nick Zasowski, Director at Global Startup Studio Network Startup studios are gaining steam across the angel investing landscape. With numbers like they are reporting, it’s easy to understand why. As the Global Startup Studio Network (GSSN) researched last year, the early signs of studio data are just the beginning for the growing expectations. Eighty-four percent of startups coming out of studios go on to raise a seed round. Of those startups that make it to the seed round, 72% advance from seed to Series A, compared to only 42% of traditional startups. Tags: Monday, January 25, 2021 By: Matt McMahon, Director – SEED (Small business Education and Entrepreneurial Development), National Institutes of Health The National Institutes of Health (NIH) is proud to be an Angel Capital Association Platinum Partner. NIH supports a dynamic portfolio of 1,500 cutting edge small businesses with over a billion dollars of non-dilutive investment every year. Angel investors can partner with NIH to help NIH-funded small businesses bring their products and services to the healthcare marketplace, where they can improve health and save lives. Tags: Sunday, January 17, 2021 By: Emily Angold, ACA Marketing Manager As an entrepreneur and seasoned angel investor, Bill Payne understands the critical importance of education to make well-informed decisions that determine the success or failure of a startup. Friday, December 18, 2020 John Guy, Manager, Emerging Companies Section Policy at Biotechnology Innovation Organization Five years ago today, the Protecting Americans from Tax Hikes (PATH) Act was signed into law. This important piece of legislation included several provisions helpful to start ups like small biotechs, including permanently extending both the R&D Credit and the Small Business Stock Gains Exclusion (Tax Code Section 1202), providing both investors and the companies they invest in security without worry of losing access to the critical incentive in the future. Tags: Monday, December 07, 2020 By: Elaine Bolle, RTP Capital Associates Rob Neville is a serial entrepreneur, and his story is a powerful testimonial about the importance of angel funding. Monday, November 23, 2020 By: Warren Spiwak, IBTX Partner ACA Affinity Partner IBTX recognizes the risk that angels and startups face. Now during these unique and extremely challenging times, these risks are more complex then ever before. IBTX Partner Warren Spiwak recently sat down with ACA to discuss what angels need to be aware of and what the IBTX team of dedicated risk management professionals can do to create innovative solutions to fit the unique needs of the startup ecosystem. Tags: Angel investing Tuesday, November 17, 2020 By: Dror Futter, Legal and Business Adviser to Startups, Venture Capital Firms and Technology Companies The SEC announced a series of amendments (likely to be effective early next year) to the rules governing private offering exemptions – by far the most frequent path for venture fundraising. The amendments retain the same “menu” of exemptions but make incremental improvements. For the early stage community, the amendments include a very useful provision that excludes “Demo Days” from being considered general solicitations provided certain conditions are met. Friday, November 13, 2020 By: Russ Krajec, CEO of BlueIron Due diligence is essential for any business deal, and IP due diligence is shockingly left out of the equation for most angel investors and venture capital investors. Tags: |